Eckert & Ziegler, a German-based isotope company, has acquired the radiopharmaceutical equipment business of Washington, D.C.-based Bioscan.

The transaction includes analytical instruments used in quality assurance of radioactive pharmaceuticals and automated radiopharmaceutical synthesis units, which are used worldwide for production of molecular imaging agents used in nuclear medicine, according to a release from the company. An Eckert & Ziegler board member said that investment will open up the company’s North American market. Meanwhile, Bioscan will focus on expanding its preclinical imaging product line, according to a spokesperson.